NEW TORK : The global revenue from the Obesity Surgery Devices Market was approximately US$ 1.64 Billion in 2022, with the global market expected to grow at a CAGR of 6.4% to reach a valuation of around US$ 3.23 Billion by the end of 2033.
As assessed by Persistence Market Research, stapling devices held a market share of around 90.2% in the global market, in 2022. The global obesity surgery devices market holds nearly 10.6% revenue share of the global surgical equipment market valued at US$ 15.5 Billion in 2022.
Obesity is a growing health concern across the globe. According to the World Health Organization (WHO), obesity has tripled worldwide since 1975. In 2016, more than 1.9 billion adults were overweight, of which over 650 million were obese. Obesity is associated with several health problems such as diabetes, hypertension, cardiovascular disease, and cancer. Obesity surgery devices are used to treat obesity by reducing the size of the stomach or by redirecting the small intestine to reduce the amount of food consumed by the patient. This report aims to provide an overview of the obesity surgery devices market, its current trends, and future prospects.
Planning Forward? Access Sample Of Obesity Surgery Devices Market Report! https://www.persistencemarketresearch.com/samples/2894
Some of the major players in the obesity surgery devices market:
How About Revitalizing The Strategy-Oriented Funnel To Stay Ahead In The Obesity Surgery Devices Market? https://www.persistencemarketresearch.com/methodology/2894
Obesity surgery is a broadly available treatment for persons with severe and complex obesity. However, inadequate insurance coverage for the procedure and excessive cost of surgery often makes it unaffordable. In addition, selective nature of obesity surgery, due to its complications, restricts growth of obesity surgery devices market. The global obesity surgery device market is estimated at USD 1,432.4 million in 2014. It is likely to grow at a CAGR of 9.6% from 2014 to 2020 to reach USD 2,489.5 million in 2020.
North America is facing serious public health problems due to obesity. The U.S. accounted for 13% of obese persons worldwide in 2013. Similarly, according to the Centers for Disease Control and Prevention (CDC), 24.5% of Americans were suffering from obesity in 2004 and this increased to 35.7% in 2011. In 2011, Roux-en-Y gastric bypass was the most common procedure in North America.
Get Premium Research Report @ https://www.persistencemarketresearch.com/checkout/2894
In Europe, obesity is a major public health challenge in Europe. According to the Organization for Economic Co-operation and Development (OECD) in 2010, approximately 52% of the population in the European Union was obese or overweight.
However, in Asia obesity has reached epidemic proportions in many countries in Asia Pacific. South East Asia and Western Pacific regions are facing an epidemic of obesity-associated diseases such as cardiovascular disorders and diabetes. China and India accounted for around 15% of the world’s obese population worldwide in 2013.
About Us:
Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
Contact Us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com